Our companion paper, Evaluating Biometric Trend Drivers: How to reflect medical breakthroughs and other drivers in forward-looking assumptions, explores the practicalities for insurers in maintaining an up-to-date view on emerging biometric trend drivers such as AOMs and provides a framework for incorporating the insured mortality impacts into insured improvement bases
Like most GLP-1 medications, they can make you tired, but the timing and intensity may vary slightly based on which drug youre taking
GLP-1s are not casual wellness products
In Semaglutide trials, four patients treated with Semaglutide had confirmed acute pancreatitis
If the answer is unclear, that itself is a signal to look elsewhere
More specifically, we identified MTP, an enzyme involved in fatty acid metabolism, as the main interacting protein of GLP-1(2836) (Supplemental Table 2) and validated this by Western blotting (Figure 5B)